FutureWorld (FWDG) 10-Q 14 Feb 17 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Dec. 31, 2016shares
Document And Entity Information
Entity Registrant Name	FUTUREWORLD CORP.
Entity Central Index Key	1,273,988
Document Type	10-Q
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	5,185,128,097
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,016

Balance Sheets (Unaudited)

Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2016	Mar. 31, 2016
Current assets
Cash	$ (1,439)	$ 5,096
Accounts receivable	0	0
Related party receivables	261,450	26,100
Inventory	0	97,805
Note receivable	0	6,710
Total current assets	260,011	135,711
Property & equipment, net of accumulated - net	4,234	499
Intangible property, net of accumulated - net	87,790	95,489
Provisional Marketable Securities	55,801,036	11,801,484
Investment in Subsidiary		0
Security Deposits	6,710	0
Total Assets	56,159,781	12,033,183
Current liabilities
Accounts payable	82,671	42,046
Accrued expenses	1,353,232	1,141,904
Misc Liabilities	(87,986)
Notes Payable	271,939	276,987
Amortization-Notes payable	(98,385)	(196,032)
Total current liabilities	1,521,471	1,264,905
Notes payable to shareholder - Related Parties	(329,425)	(384,539)
Total liabilities	1,192,046	880,366
Stockholders' Equity
Preferred stock, $.0001 par value, 100,000,000 shares authorized, 10,000,000 and 201,000 shares issued and outstanding	201,000	1,000
Common stock, $.0001 par value, 14,900,000,000 shares authorized, 5,185,128,097 and 2,807,089,397 shares issued and outstanding, respectively	518,513	280,710
Additional paid-in capital	7,009,934	7,034,632
Provisional Marketable Securities	55,801,036	11,801,484
Accumulated deficit	(8,605,189)	(7,964,009)
Total Stockholders' Equity	54,967,735	11,152,817
Total Liabilities and Stockholders' Equity	$ 56,159,781	$ 12,033,183

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2016	Mar. 31, 2016
Shareholder's Equity
Preferred stock, par value per share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	10,000,000	201,000
Preferred stock, shares outstanding	10,000,000	201,000
Common stock, par value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	14,900,000,000	14,900,000,000
Common stock, shares issued	5,185,128,097	2,807,089,397
Common stock, shares outstanding	5,185,128,097	2,807,089,397

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Revenues	$ 0	$ 9,773
Direct costs	0	1,210
Intercompany Billing	261,450	0
Gross Profit	261,450	8,563
Operating expenses:
Salaries and benefits	165,838	238,268
Consulting	207,800	2,650
Professional fees	66,550	8,577
General and administrative	88,836	12,865
Amortization and depreciation	209,255	33,672
Total operating expenses	738,279	296,032
Other income (expense):
Interest expenses	(77,583)	(44,848)
Sale of assets, net	0	0
Total other (expense)	(77,583)	(44,848)
Loss from operations before income taxes	(554,412)	(332,317)
Provision for income taxes	0	0
Loss from operations before minority interest	(554,412)	(332,317)
Net loss	$ (554,412)	$ (332,317)
Earnings (loss) per share: Basic	$ 0	$ 0
Weighted average shares outstanding Basic	3,953,397,752	1,363,628,371

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flows from Operating Activities:
Net (loss) income	$ (554,412)	$ (332,317)
Cash provided by operations:
Depreciation and amortization	8,838	8,097
Stock based compensation	200,000
Interest Expense	77,583
Amortization of debt discount	112,647	33,672
Changes in assets and liabilities:
Accounts receivable		0
Related Party Receivable	(215,703)	0
Inventory	0	(2,663)
Due from affiliate	0	0
Miscellaneous	8,319	0
Prepaid and other	0	4,269
Accounts payable	35,417	(5,131)
Accrued expenses	152,931	192,077
Net Cash (Used) Provided by Operating Activities	(174,380)	101,996
Cash flows from Investing Activities:
Office Equipment	(4,874)	0
Net Cash (Used) Provided by investing Activities	(4,874)	0
Cash Flows from Financing Activities:
Proceeds from issuance of note payable	42,500	0
Repayments of notes payable	110,293	112,168
Proceeds from sale of assets
Related party advances	22,804
Net Cash Provided (Used) by Financing Activities	175,597	112,168
Net increase/decrease in Cash	(3,658)	10,172
Cash at beginning of period	(5,096)	3,715
Cash at end of period	(1,438)	13,887
Supplemental cash flow information:
Interest paid	0	0
Taxes paid	$ 0	$ 0

1. History of the Company and N

1. History of the Company and Nature of the Business	9 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
History of the Company and Nature of the Business	1. History of the Company and Nature of the Business “We”, “us” and “our” refer to FutureWorld Corp., a Delaware corporation. On September 11, 2015, the Company changed its name to FutureWorld Corp. Nature of Business The address of our executive offices is: 3637 4th Street North, Saint Petersburg, FL 33704 and our telephone number at that address is 727-474-1816. The address of our web site is www.futureworldcorp.com. The information at our web site is for general information and marketing purposes and is not part of this annual report for purposes of liability for disclosures under the federal securities laws. FutureWorld (FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. As the only Cannabis Technology Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (Industrial Hemp) for foreseeable future; bringing value to its core and its shareholders. FutureWorld Corp. is seeking to acquire minority or full interest in currently operating companies and disruptive technologies in the Industrial Hemp/Medical and Recreational Cannabis Industry globally; such as vaporizers, lab testing, tracking systems, security, CBD oil, testing kits, financial solutions, dispensaries and other needed components. Our goal is to provide our acquired companies, current and future shareholders a clear strategy for the growth of their companies and their investment in those companies. We currently provide multiple products that supply the burgeoning cannabis industry through our portfolio companies. The "picks and shovel" business model capitalizes of selling enterprises associated with the Industrial Hemp and Medical Cannabis industries products that are essential in their success. Our products solve long standing problems in cultivation, processing, and retail sales for industrial hemp and medical cannabis. The following divisions will continue to delve even further into purchasing existing products or developing brand new products as the wholesale and retail space continues to evolve. In addition, one primary focus is to manufacture, market, and sell products containing hemp derived CBD oil. Cannabis industry is the fastest-growing industry in the United States and had its biggest year ever which could grow by another eight to 10 states in 2016. With the presidential election looming, there is guaranteed to be a massive voter turnout and the initiatives that are poised to include legalization of cannabis on the 2016 ballot stand a chance to make some big changes. The cannabis ballot initiatives could open the door to legalization in more states including Arizona, California, Maine, Massachusetts, Michigan and Nevada in 2016. This rapid growth of the industry is a boom for ancillary products providers such as HempTech, CB Scientific, Bioceutical Sciences, Apotheca Earth and incubators such as FutureWorld Corp (FWDG). A majority of Americans continue to support full legalization, nationally, and by 2016, it's entirely possible that marijuana could be a wedge issue in the presidential election. On the industrial Hemp side, with the 2014 Agricultural Act (known as the Farm Bill) making year 2014 notable and celebrated, 2015 proved to be a year of record-setting, transformative strides within the industrial hemp industry. Laws governing industrial hemp continued to evolve in more and more states, making Industrial Hemp one of most lucrative opportunities to unfold over the course of the year and beyond. In short, the Cannabis industry will grow from $1.5 billion in 2014 to an estimated $35 billion in 2020. Who We Are FutureWorld focuses on the identification, acquisition, development, and commercialization of cannabis related products and services. As a Cannabis Technology Incubator and Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (including Industrial Hemp) combining resources to strengthen the company and the industry. FutureWorld follows a well-tested business incubation model; the seed fund model. The seed fund model thesis is based on a combination of “high-quality filter” and “broad portfolio” approaches. The high-quality filter attempts to ensure that the very best minds, teams and ideas get into FWDG. The broad portfolio approach, statistically, discovers a few breakaway companies in order to provide the big returns to investors. So far the Company has funded 6 companies in 2015 and expects to fund more in 2016. How We Make Money We make money by exiting our incubated companies through a sale, reverse merger, merger or an IPO. In any case, some or all of the proceeds, whether in stock or cash, will be returned to the shareholders as dividend. For FutureWorld, our main revenue is derived from cash and marketable securities through our exits. In most cases we own from 19% to 100% of the companies being incubated by FWDG. According GAAP, we would need to consolidate the financials of all the holdings until they are sold or spun off. Products or services revenue generation by our companies is not our business model, as an incubator, but only a successful exit will define our revenue stream. Our Companies, Current and Future Results Four areas within the cannabis industry sector with the most accelerated growth for 2016 and beyond includes; Medicine – Accessories – Testing – Grow Delivery and Land Leasing. We have and will use this guide to incubate exciting companies for better ROI. All of our companies fall within all of these important areas; Medicine & Nutraceuticals • Apotheca Earth - http://apothecaearth.com/ We incubated a distribution company called “Apotheca Earth” in 2015 to sell our designed and manufactured products online and offline. The distribution company provides sales channels for CB Scientific, Bioceutical Sciences and any other businesses within FWDG universe and beyond. The company has had limited sales so far since we are in the beta stage. CBD Oil- CBD is one of at least 60 cannabinoids found in hemp, and is non-psychoactive. The Cannabidiol “CBD” is a compound in cannabis that has significant medical effects, but does not make people feel “high” and can actually counter the psychoactive effects of THC. The reduced psychotropic of CBD-rich cannabis makes it an appealing treatment option for patients seeking anti-inflammatory, anti-pain, anti-anxiety, anti-psychotic, and/or anti-spasm effects without disconcerting lethargy. Scientific and clinical studies underscore CBD’s potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuro-protective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere. Apotheca Earth has sourced its own CBD oil from Europe. We are also developing plans to fund an overseas hemp cultivation project to provide a consistent and reliable supply to the United States and beyond. Currently, industrial hemp cultivation is legal in twenty countries around the world. NutraCann’s products are sold under the brand name “cbdessence” on CBDESSENCE.COM. Apotheca Earth will process the CBD oils that will be sold through our online presence for retailing industrial hemp oil-based Cannabidiol (CBD) nutritional supplements, wellness and personal care products and vapable CBD oils. Apotheca Earth will market items such as CBD oil, CBD infused edibles & multiple hemp related items and cross market our vaporizers from URVape.com. Apotheca Earth will be featuring scientific grade hemp oil which is highly sought after around the world. We will sell already recognizable brands including our own brands and drive internet sales through ads, videos, social media and Search Engine Optimization. The global Nutraceutical market is projected to be in excess of $200 billion by 2015 and the current US Nutraceutical and Dietary supplement market is valued at around $42 billion. CBDESSENCE.com and URCBDOil.com will be at the forefront of this massive marketplace with significant opportunities. Cannabinoids (non-psychoactive CBD) have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and auto-immune diseases. Cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic events, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's, Parkinson's and HIV dementia. URCBDOil.com should be live by July 1, 2015 UPDATE). We have been experimenting on labeling and branding for new products. We will be introducing the brands shortly. We have high hopes for this company. NutraCann became part of CB Scientific with its IPO in April 2016. These are the stats on this company; · Founded – April 2015 · Investment - $150K · Revenue for 2015 – Less than $50K · Achievements – Successfully tested CBD Vape blends, Tinctures and Pills sold on EBay, Amazon and its website. Signed up multiple resellers around the country and in Europe. · Estimated 2016 revenue – Pro Forma Financials only available · Estimated Exit – Became part of CB Scientific with its IPO in March 2016 · Estimated Exit Type – Merged with CB Scientific (CBSC) · Comparable company – Cannavest (CANV), Medical Marijuana (MJNA) · Facebook page: https://www.facebook.com/nutracannlabs · Bioceutical Sciences Founded in 2015, this company has the most exciting potentials. We founded this company to get into the pharmaceutical aspect of the cannabis industry in which should be the biggest driver. The company develops, designs and manufactures Pharma grade Nutraceuticals for cancer, Alzheimer and life threatening illnesses for patients by proprietary formulations using cannabinoids derived from Cannabis. The company will also provide formulations and designs for NutraCann and CB Scientific. There are major funding requirement for this company which will come from PPM, grants and sales. Bioceutical Sciences became part of CB Scientific with its IPO in March 2016. This is one of most promising of our companies within the FWDG and cannabis universe. These are the stats on this company; · Founded – May 2015 · Investment - $45K · Revenue since inception – Less than $30K · Achievements – Formulated pre-pharmaceutical and Nutraceutical grade CBD blends, pills and tinctures for Apotheca Earth. The company also completed the development of next generations of CB Scientific’s test kits. Estimated 2016 revenue – Pro Forma Financials only available · Estimated Exit – Became part of CB Scientific with its IPO in March 2016 · Estimated Exit Type – Merged with CB Scientific (CBSC) · Comparable company – Cannabis Sciences (CBIS), Cannabis Sativa (CBDS) · Facebook page: https://www.facebook.com/bioceuticalsciences · Magic Dragon Brands Started in September 2015, Magic Dragon Brands is testing formulations for the Hempseed infused energy and chill drinks for the consumers under the brand "Magic Dragon High". Magic Dragon High Brands will initially produce Hempseed and Hemp based CBD infused beverages. According to new market data from Packaged Facts; the energy drinks sector comprises an increasing portion of the non-alcoholic beverage market, and as the sector, has grown 60% from 2008-2012 with a total U.S. sales of more than $12.5 billion in 2012. According to "Energy Drinks & Shots Market Trends in the U.S.", sales of energy drinks will grow to a value of $21.5 billion by 2017, driven by expansion in retail distribution, and strong potential in new product development. Packaged Facts also estimates that convenience stores hold the largest share of market sales (59%), followed by mass merchandisers (13%), supermarkets (10%), club stores/warehouse (5%), and drug stores (2%). In aggregate, all other retailers contribute a significant 11% to market sales. We are expecting to introduce the line shortly with the finalization of the logistics. Founded – September 2015 Investment – Minimal Revenue since inception – None Estimated 2016 revenue - Pro Forma Financials only available Estimated Exit – Became part of CB Scientific with its IPO in March 2016 Estimated Exit Type – Merged with CB Scientific (CBSC) Comparable company – Rocky Mountain High (RMHB) Facebook page: https://www.facebook.com/magicdragonhigh Testing & Analytics • CB Scientific - http://www.test4cbd.com/shop/ - http://corp.cbscientific.com/ We started this company in March 2014 to design, develop and manufacture LST (Life Science Tools) for Cannabis and agricultural industry. Our first products were THC and CBD cannabis testing personal kits which won product of the year in 2014. The sales are ramping up and we expect 1000% or more growth in 2016. The company is also in development of other major products for non-cannabis market to be unveiled in 2016. We are in the process of seeking investment for manufacturing, sales and marketing to propel the revenue. The company also has had a major setback with previous employees stealing major contracts causing financial and product roadmap delays. The company has since recouped and expecting profitable 2016. These are the stats on this company; Founded – April 2014 Investment - $350K Revenue since inception – around $200K Achievements – developed the only personal test kits in the industry for THC and CBD, won best product award in only three month of development, increased sales from 0 test kits to thousands through multiple sales channels in 2015. Brought to market the only ubiquitous, easy to use, all in one, ISO certified laboratory test kits to the world. Estimated 2016 revenue - $1M to $2M with 100% Q to Q growth Estimated Exit – Went public in March 2016 Ticker Symbol - CBSC Market Cap - $102M Close Comparable – No direct competitors Estimated FWDG Holding Value - $20,000,000 Estimated ROI - 5000%, expected to reach 10,000% by the end of 2017 Facebook page: https://www.facebook.com/cbscientificinc Grow Systems • HempTech Corp - https://hemptechcorp.com/main/ We started this company in September 2014 to design and develop state-of-the-art automation for grow facilities all across the agricultural industry, including the Cannabis market. In late 2015, the company finished development of its first major product called grow-droid which is plug n play and comes fully automated for growers to grow their cannabis for more yield and profitability. HempTech has been successful in signing its largest contract post development with a company representing Indian tribes in Canada and the States to sell more than 1000 grow pods called grow.droid II, for the next six years. Contract potential is more than $160M for the next six years. The company has also signed its first exclusive reseller agreements in Colorado, California, Washington and Oregon and expects sales to start in September 2016. The company is in the process of signing up distributors in the State of Arizona, Nevada and Massachusetts. This company will be our biggest driver on revenue and market capitalization in the FWDG universe. The company is in development of non-cannabis farm pods for local urban agriculture. These are the stats on this company; · Founded – April 2014 · Investment - $400K in direct investment (and $2.5M in indirect investment by a third party) · Revenue since inception – None · Achievements – Developed agricultural industry’s only analytical automation with environmental controls. Cannabis industries only plug n play growing kit with complete environmental automations and analytics scalable from 16 plants to thousands, cutting the time to grow from 28 weeks to only 3 weeks. Only company to offer “Profiling” for grow consistency and profitability. · Estimated 2016 revenue – Pro Forma of $2M to $10M with 100% Q to Q growth · Estimated Exit – Went public in March 2016 · Ticker Symbol - HTCO · Market Cap - $278M · Close Comparable – Surna (SRNA), Terra Tech (TRTC) · Estimated FWDG Holding Value - $32,500,000 · Estimated ROI – 9000%, expected to reach 15000% by the end of 2017 · Facebook page: https://www.facebook.com/hemptechcorp Land Leasing · FutureLand Corp - http://futurelandcorp.com/ Founded in September 2014, FutureLand Corp., a Colorado company, is a cannabis and hemp specialty zoned land leasing company formed to capitalize upon the emerging global cannabis market. FutureLand, focuses on target acquisition, zoning, license fulfillment, site plan preparation and financing of cannabis or hemp grow facilities throughout the United States. We give growers the opportunity to grow. Company monetizes through leasing the land, leasing the structures on the land, financing interest revenue and management fees associated with cultivation centers. FutureLand retains ownership of all the land and the structures. FutureLand leases to both medical marijuana, retail marijuana as well as industrial hemp growers. FutureLand does not currently grow, distribute or sell marijuana. Company has multiple projects across the USA and possible project in Jamaica. · Founded – September 2015 · Investment – Minimal · Revenue since inception – None · Estimated 2016 revenue - Pro Forma Financials only available · Estimated Exit – Became part of CB Scientific with its IPO in March 2016 · Estimated Exit Type – Merged with CB Scientific (CBSC) · Comparable company – Rocky Mountain High (RMHB) · Facebook page: https://www.facebook.com/magicdragonhigh · Founded – April 2014 · Investment - $350K · Revenue since inception – around $200K · Achievements – developed the only personal test kits in the industry for THC and CBD, won best product award in only three month of development, increased sales from 0 test kits to thousands through multiple sales channels in 2015. Brought to market the only ubiquitous, easy to use, all in one, ISO certified laboratory test kits to the world. · Estimated 2016 revenue - $1M to $2M with 100% Q to Q growth · Estimated Exit – Went public in March 2016 · Ticker Symbol - CBSC · Market Cap - $102M · Close Comparable – No direct competitors · Estimated FWDG Holding Value - $20,000,000 · Estimated ROI - 5000%, expected to reach 10,000% by the end of 2017 · Facebook page: https://www.facebook.com/cbscientificinc · Founded – September 2014 · Investment - Less than $110K · Achievements – Purchased 240+ acres of land in southern Colorado that has increased in value by a factor of 10. Purchased 50% interest in a recreational property in Oregon going live in the third quarter 2016. · Estimated 2016 revenue – Pro Forma of $1M to $2M · Exited – April 2015 · Exit Type – Merger · Ticker Symbol - FUTL · Market Cap - $1.2M · Close Comparable – Zoned Properties (ZDPY) · Estimated FWDG Holding Value - $600,000 · Estimated ROI - 600%, expected to reach 6000% by the end of 2016 · Facebook page: https://www.facebook.com/futurelandcorp

2. Basis of Presentation, Busin

2. Basis of Presentation, Business and Summary of Significant Accounting Policies	9 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Basis of Presentation, Business and Summary of Significant Accounting Policies	2. Basis of Presentation, Business and Summary of Significant Accounting Policies Basis of Presentation In the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of (a) the results of operations for the three and six months ended December 31, 2016 and 2015: (b) the financial position at December 31, 2016 and March 31, 2016 and (c) cash flows for the three and three months ended December 31, 2016 and 2015, have been made. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not included all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. For further information regarding the Company's significant accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in the Company's Annual Report on from 10-K for the year ended March 31, 2016 filed with the Securities and Exchange Commission on August 12, 2015. Our financial statements may not be comparable to companies that comply with public company effective dates. Due to our election not to opt out of the extended transition period that allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. All amounts referenced in these Financial Statements and this Report are in US Dollars unless otherwise stated. Nature of the Business, and History of the Company and its Subsidiaries The nature of the business and the history of the Company and its subsidiaries are as follows: Nature of the Business FutureWorld Corp., a Delaware corporation, is a U.S. diversified Hemp/Cannabis Company, listed on the Over the Counter exchange, which was originally formed to capitalize on the burgeoning markets in renewable and alternative energy technologies, but has since changed direction and moved into the Hemp/Cannabis space. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of Hemp/Cannabis products, services and technologies globally. FutureWorld is seeking to acquire minority or full interest in currently operating companies and disruptive technologies in the Industrial Hemp/Medical and Recreational Cannabis Industry globally; such as vaporizers, lab testing, tracking systems, security, CBD oil, testing kits, financial solutions, dispensaries and other needed components. Our goal is to provide our acquired companies, current and future shareholders a clear strategy for the growth of their companies and their investment in those companies. Principles of Consolidation The consolidated financial statements include the accounts and operations of FutureWorld Corp., and its portfolio companies, HempTech Corp., FutureLand, and CB Scientific. Basis of Accounting The Company maintains its financial records and financial statements on the accrual basis of accounting, in conformity with generally accepted accounting principles in the United States of America. The accrual basis of accounting provides for matching of revenues and expenses in the period they were earned and incurred. Cash and Cash Equivalents For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or designated for assets acquisitions, and certificates of deposit that have an original maturity of three months or less when purchased, to be cash equivalents. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. Fair Value of Financial Instruments The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: ● Cash and Cash Equivalents, Accounts Receivable, Prepaid Expenses, Accounts Payable, and Accrued Expenses The carrying amount reported in the balance sheets for these items approximates fair value because of the short maturity of these instruments. ● Loans and Notes Payable to Related Parties: The carrying value of loans and notes payable to related parties approximates fair value as each of the notes payable carries an interest rate commensurate with commercial borrowing rates available to the Company. As of December 31, 2016 and March 31, 2016, the fair values of the Company's financial instruments approximate their historical carrying amount. Accounts Receivable Accounts receivable consist of amounts due for the delivery of Product sales to customers. An allowance for doubtful accounts is considered to be established for any amounts that may not be recoverable, which is based on an analysis of the Company's customer credit worthiness, and current economic trends. Based on management's review of accounts receivable, no allowance for doubtful accounts was considered necessary as of period end. Receivables are determined to be past due, based on payment terms of original invoices. The Company does not typically charge interest on past due receivables. Balances on Current sales are due in 60 days from the date of sale. Inventory N/A Property and Equipment Property and equipment are recorded at historical cost. Depreciation is computed on the straight-line method over estimated useful lives of the respective assets, ranging from three to seven years. The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation periods or the unamortized balance is warranted. Based upon the Company's most recent analysis, management believes that no impairment of property and equipment exists at December 31, 2016 and March 31, 2016. Intangible assets Intangible assets are recorded at cost and amortized over their useful lives. The Company's goodwill associated with its acquisitions is not amortized. Management reviews goodwill and provisional marketable securities for impairment at least on an annual basis and at other times when existing conditions raise substantial questions about their recoverability. Impairment of Long-Lived Assets Periodically, the Company assesses the recoverability of the Company's intangible assets, consisting of the Intellectual Property & licensing and its trademark, and record an impairment loss to the extent that the carrying amounts of the assets exceed its fair value. Based upon management's most recent analysis, the Company believes that no impairment of the Company's tangible or intangible assets exist at December 31, 2016 and March 31, 2016. Revenue Recognition Our revenue is arrived by exiting our incubated companies through a sale, reverse merger, merger or an IPO. In any case, some or all of the proceeds, whether in stock or cash, will be returned to the shareholders as dividend. For FutureWorld, our main revenue is derived from cash and marketable securities through our exits. In most cases we own from 19% to 100% of the companies being incubated by FWDG. According GAAP, we would need to consolidate the financials of all the holdings until they are sold or spun off. Products or services revenue generation by our companies is not our business model, as an incubator, but only a successful exit will define our revenue stream. Foreign currency translation The Company's functional currency and its reporting currency is the United States Dollar. Cost of Goods Sold N/A Stock Based Compensation The Companies estimate the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model. For stock-based awards issued to employees and directors, stock-based compensation is attributed to expense using the straight-line single option method, which is consistent with how the prior-period pro-forma were provided. Stock-based compensation expense recognized in the Statements of Operations for the three and three months ended December 31, 2016 and 2015 included compensation expense for share-based payment awards granted prior to, but not yet vested based on the grant date fair value estimated and compensation expense for the share-based payment awards granted subsequent to January 1, 2015 based on the grant date fair value estimated. The Company's determination of fair value of share-based payment awards to employees and directors on the date of grant using the Black-Scholes model, which is affected by the Company's stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. Income Taxes The Company records federal and state income tax liability at the federal and state rates after allowances. Deferred income taxes are provided on the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Tax benefit from an uncertain tax position may be recognized in the financial statements when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. Income tax positions must meet a more-likely-than-not recognition threshold at the effective date to be recognized and in subsequent periods. The Company adopted a policy under which, if required to be recognized in the future, they will classify interest related to the underpayment of income taxes as a component of interest expense and will classify any related penalties in selling, engineering, general and administrating expenses in the statement of operations. Advertising Costs Advertising costs are charged to operations as incurred. Earnings (Loss) Per Share Basic EPS is calculated by dividing earnings (loss) available to common shareholders by the weighted average number of common shares outstanding during each period. Diluted EPS is similarly calculated, except that the denominator includes common shares that may be issued subject to existing rights with dilutive potential, except when their inclusion would be anti-dilutive. Based on an estimated current value of the Company's stock being equal to or less than the exercise price of the warrants, none of the shares assumed issued upon conversion of the warrants, nor any of the stock assumed issued under the Company's Incentive Stock Plan are included in the computation of fully diluted loss per share, since their inclusion would be anti-dilutive. Impact of Recently Issued Accounting Pronouncements In April 2015, the FASB issued ASU 2015-08, Presentation of Financial Statements and Property, Plant, and Equipment. ASU No. 2015-08 defines a discontinued operation as disposal of components of an entity that represents a strategic shift that has or will have a major effect on an entity's operations. ASU No. 201508 also requires a reporting entity to present the assets and liabilities of a disposal group that includes a discontinued operation separately in the asset and liability sections, respectively, of the statement of financial position for each comparative period. ASU 2015-08 becomes effective for interim and annual periods beginning on or after December 15, 2015. Adoption of ASU 2015-08 is not expected to have a significant impact on the Company's consolidated financial statements. In August 2015, the FASB issued ASU 2015-15, Presentation of Financial Statements-Going Concern. This statement provides US GAAP guidance on management's responsibility in evaluation whether there is substantial doubt about a company's ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company's ability to continue as a going concern within one year from the date the financial statements are issued. The ASU is effective for annual periods ending after December 15, 2016 and interim periods thereafter. In November 2015, the FASB issued ASU 2015-16-Derivatives and Hedging: Determining Whether the Host contract in a Hybrid Financial Instrument issued in the Form of a Share is More Akin to Debt or to Equity. Certain classes of shares include features that entitle the holders to preferences and rights (such as conversion rights, redemption rights, voting powers and liquidation and dividend payment preferences) over the other shareholders. Shares that include embedded derivative features are referred to as hybrid financial instruments, which must be separated from the host contract and accounted for as a derivative if certain criteria are met. This ASU is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2015 Other recent accounting pronouncements issued by the FASB, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

3. Going Concern

3. Going Concern	9 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	3. Going Concern For the quarter ended December 31, 2016, the Company incurred a net loss of $106,306 and a cumulative net loss since inception of $8,157,078. As of December 31, 2016, the Company had cash of $53,247 and working capital deficit of $33,698 with which to satisfy any future cash requirements. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company depends upon capital derived from selling our marketable securities and future financing activities such as loans from its officers and directors, subsequent offerings of its common stock or debt financing in order to operate and grow the business either directly or through its subsidiary. There can be no assurance that the Company will be successful in raising such capital. The key factors that are not in the Company's control and that may have a direct bearing on operating results. These factors include, but are not limited to, acceptance of the Company's business plan, the ability to raise capital in the future, the ability to expand its customer base, and the ability to hire key employees to grow the business. There may be other risks and circumstances that management may be unable to predict.

4. Property and Equipment

4. Property and Equipment	9 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property and Equipment	4. Property and Equipment Property and equipment as of December 31, 2016 and March 31, 2016 consists of the following: December31 2016 March 31, 2016 Computer equipment $ 6,684 $ 1,810 Furniture and fixtures 0 0 - Accumulated depreciation (2,450 ) (1,3118 ) Net $ 4,234 $ 449

5. Intangibles

5. Intangibles	9 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Intangibles	5. Intangibles For the nine months ended December 31, 2016, the amortization expense for intangible assets was $1,139 and $7,170, respectively. December 31, 2016 March 31, 2016 HempTech Product Technology $ 102,659 $ 95,486 Trademarks 0 - Accumulated Amortization 14,869 Intangibles, Net $ 87,790 $ 95,486

6. Stock Options and Awards

6. Stock Options and Awards	9 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Options and Awards	6. Stock Options and Awards None

7. Accrued Expenses

7. Accrued Expenses	9 Months Ended
	Dec. 31, 2016
Payables and Accruals [Abstract]
Accrued Expenses	7. Accrued Expenses Accrued expenses at December 31, 2016 and March 31, 2016 were as follows: December 31, 2016 March 31, 2016 Accrued salaries and payroll taxes $ 1,117,737 $ 925,649 Accrued interest 235,495 216,255 Accrued penalties - $ 1,353,232 $ 916,366

8. Related Parties Disclosures

8. Related Parties Disclosures	9 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Related Parties Disclosures	8. Related Parties Disclosures Loan from Saeed (Sam) Talari Mr. Talari has advanced funds to the Company at various times. On April 1, 2010 the Company issued a promissory note with an initial balance of $306,319 bearing interest at 5%. This note allows Mr. Talari to advance additional funds to the Company as needed. At December 31, 2016 and March 31, 2016, the balance due to Mr. Talari on this Promissory Note is $190,681 and $299,118 respectively, and the accrued interest thereon at December 31, 2016 and March 31, 2016 is $67,511 and $45,048 respectively.

9. Employment Agreements

9. Employment Agreements	9 Months Ended
	Dec. 31, 2016
Compensation and Retirement Disclosure [Abstract]
Employment Agreements	9. Employment Agreements Sam Talari On January 1, 2012, the Company entered into a three-year Employment Agreement with Mr. Talari, the Company's Acting Chief Executive Officer, and one of the Company's directors. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $8,500 per month, with a 5% increase per annum and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees. On January 1, 2015, the Company increased Mr. Talari's base salary to $10,849 per month based on a new three years employment agreement. John Verghese On January 1, 2015, the Company entered into a three-year employment agreement with John Verghese as the CEO of HempTech Corp. The Agreement provides for (a) a base salary of $10,000 per month, (b) two weeks' vacation within one year of the starting date, and (c) all group insurance plans and other benefit plans and programs made available to the Company's management employees. Additionally Mr. Verghese has been granted 10% option of HempTech common stock at par value. Karin Rohret On January 2nd, 2010, the Company entered into an employment agreement with Karin Rohret as part-time Controller. The Agreement provides for (a) a base salary of $1,101.67 per month, (b) a signing bonus of $20,000 by the way of Company's common stock within 30 days of signing the agreement. Additionally Ms. Rohret will be eligible to receive a grant of 600,000 shares of common stock at founder level with a par value of 0.001. Vesting of the grant shall be at the rate of 200,000 shares on each anniversary from the signing of the agreement. The salary was adjusted to $2,950 on October 1 2015 as the position required additional hours.

10. Office Space

10. Office Space	9 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Office Space	10. Office Space The address of our executive offices is: 10901 Roosevelt Blvd, Suite 1000c, Saint Petersburg, FL 33716 and our telephone number at that address is 727-474-1816. We maintain our executive's offices in a 13K square feet office and warehouse space. We believe the facilities are adequate for our operational needs. We may require additional offices in the event of further expansions.

11. Stockholders' Equity

11. Stockholders' Equity	9 Months Ended
	Dec. 31, 2016
Equity [Abstract]
11. Stockholders' Equity	11. Stockholders' Equity Preferred Stock: The Company has 100,000,000 shares of $0.0001 par value stock Authorized. 210,000,000 shares have been issued or are outstanding as of December 31, 2016. Common Stock: The Company has 14,900,000,000 shares of $0.0001 par value stock Authorized. As of December 31, 2016, 5,185,128,097 shares were issued and outstanding.

12. Subsequent Events

12. Subsequent Events	9 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
12. Subsequent Events	12. Subsequent Events None.

4. Property and Equipment (Tabl

4. Property and Equipment (Tables)	9 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property and equipment	December31 2016 March 31, 2016 Computer equipment $ 6,684 $ 1,810 Furniture and fixtures 0 0 - Accumulated depreciation (2,450 ) (1,3118 ) Net $ 4,234 $ 449

5. Intangibles (Tables)

5. Intangibles (Tables)	9 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Amortization expense for intangible assets	December 31, 2016 March 31, 2016 HempTech Product Technology $ 102,659 $ 95,486 Trademarks 0 - Accumulated Amortization 14,869 Intangibles, Net $ 87,790 $ 95,486

7. Accrued Expenses (Tables)

7. Accrued Expenses (Tables)	9 Months Ended
	Dec. 31, 2016
Payables and Accruals [Abstract]
Accrued expenses	December 31, 2016 March 31, 2016 Accrued salaries and payroll taxes $ 1,117,737 $ 925,649 Accrued interest 235,495 216,255 Accrued penalties - $ 1,353,232 $ 916,366

4. Property and Equipment (Deta

4. Property and Equipment (Details) - USD ($)	Dec. 31, 2016	Mar. 31, 2016
Property, Plant and Equipment [Abstract]
Computer equipment	$ 6,684	$ 1,810
Furniture and fixtures	0	0
Accumulated depreciation	(2,450)	(13,118)
Net	$ 4,234	$ 449

5. Intangibles - 5. Amortizatio

5. Intangibles - 5. Amortization expense for intangible assets (Details) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2016	Mar. 31, 2016
Property, Plant and Equipment [Abstract]
HempTech Product Technology	$ 102,659	$ 95,486
Trademarks	0	0
Accumulated Amortization	14,869	0
Intangibles, Net	$ 87,790	$ 95,486

5. Intangibles (Details Narrati

5. Intangibles (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2016	Mar. 31, 2016
Property, Plant and Equipment [Abstract]
amortization expense	$ 14,869	$ 0

7. Accrued Expenses (Details Na

7. Accrued Expenses (Details Narrative) - USD ($)	Dec. 31, 2016	Mar. 31, 2016
Payables and Accruals [Abstract]
Accrued salaries and payroll taxes	$ 1,117,737	$ 925,649
Accrued interest	235,495	216,255
Accrued expenses	$ 1,353,232	$ 916,366

8. Related Parties Disclosures

8. Related Parties Disclosures (Details Narrative) - USD ($)	Dec. 31, 2016	Mar. 31, 2016	Apr. 01, 2010
Debt Disclosure [Abstract]
Promissory note initial balance			$ 306,319
Interest rate			500.00%
Current balance due on Promissory note	$ 82,671	$ 42,046	$ 190,681
Accrued interest on Promissory Note	$ 67,511	$ 45,048